Saba Capital Amends 13D Filing for Nuveen MA Muni Fund

Ticker: NMT · Form: SC 13D/A · Filed: Oct 2, 2024 · CIK: 897419

Nuveen Massachusetts Quality Municipal Income Fund SC 13D/A Filing Summary
FieldDetail
CompanyNuveen Massachusetts Quality Municipal Income Fund (NMT)
Form TypeSC 13D/A
Filed DateOct 2, 2024
Risk Levelmedium
Pages4
Reading Time5 min
Key Dollar Amounts$0.01
Sentimentneutral

Sentiment: neutral

Topics: 13D-filing, activist-investor, municipal-bond-fund

TL;DR

Saba Capital just updated its stake in Nuveen MA Muni Fund - watch this space.

AI Summary

Saba Capital Management, L.P. has filed an amendment (No. 3) to its Schedule 13D on October 2, 2024, regarding Nuveen Massachusetts Quality Municipal Income Fund. The filing indicates a change in beneficial ownership, with Saba Capital Management now holding a significant stake in the fund's common shares.

Why It Matters

This filing signals potential activist investor interest or a shift in control dynamics for the Nuveen Massachusetts Quality Municipal Income Fund, which could impact its management and shareholder value.

Risk Assessment

Risk Level: medium — Changes in beneficial ownership filings like this can precede activist campaigns or significant strategic shifts, introducing uncertainty.

Key Players & Entities

FAQ

What is the specific change in beneficial ownership reported in this amendment?

The filing is an amendment (No. 3) to Schedule 13D, indicating a change in beneficial ownership, but the exact percentage or number of shares acquired/disposed of is not detailed in the provided text snippet.

Who is filing this amendment?

Saba Capital Management, L.P. is filing this amendment.

What is the subject company of this filing?

The subject company is Nuveen Massachusetts Quality Municipal Income Fund.

When was this amendment filed?

This amendment was filed on October 2, 2024.

What is the CUSIP number for the common shares of Nuveen Massachusetts Quality Municipal Income Fund?

The CUSIP number for the common shares is 67061E104.

Filing Stats: 1,230 words · 5 min read · ~4 pages · Grade level 8.5 · Accepted 2024-10-02 20:27:40

Key Financial Figures

Filing Documents

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: October 2, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 67061E104 SCHEDULE 13D/A Page 7 of 7 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital during the past sixty days. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 8/8/2024 Sell 11,181 11.26 8/9/2024 Sell 5,173 11.32 8/12/2024 Sell 7,644 11.30 8/13/2024 Sell 4,368 11.26 8/14/2024 Sell 11,887 11.39 8/15/2024 Sell 10,779 11.31 8/16/2024 Sell 7,513 11.32 8/19/2024 Sell 5,129 11.34 8/20/2024 Sell 9,140 11.35 8/21/2024 Sell 4,576 11.37 8/22/2024 Sell 8,102 11.39 8/23/2024 Sell 4,803 11.36 8/26/2024 Sell 8,164 11.38 8/27/2024 Sell 9,022 11.34 8/28/2024 Sell 5,592 11.33 8/29/2024 Sell 8,546 11.34 8/30/2024 Sell 9,598 11.33 9/3/2024 Sell 8,600 11.36 9/4/2024 Sell 27,686 11.40 9/5/2024 Sell 15,710 11.39 9/6/2024 Sell 17,710 11.38 9/9/2024 Sell 12,149 11.40 9/10/2024 Sell 12,523 11.43 9/11/2024 Sell 10,532 11.45 9/12/2024 Sell 26,938 11.52 9/13/2024 Sell 12,785 11.46 9/16/2024 Sell 27,768 11.52 9/17/2024 Sell 35,514 11.51

View Full Filing

View this SC 13D/A filing on SEC EDGAR

View on Read The Filing